MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$239K
Net Income
-$11,260K
Net Profit Margin
-4711.30%
EPS
-$0.31
Unit: Thousand (K) dollars
Revenue Breakdown
Laboratory Services
Kitted Products
Revenue Breakdown
US
Europe
Asia Pacific
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenue
239
32
2,889*
260
Cost of revenues
82
17
1,317*
121
Cost of revenues amortization of acquired intangibles
-
-
7*
0
Gross profit
157
15
1,565*
139
Research and development
4,486
4,953
16,112*
3,878
Sales and marketing
1,916
2,402
2,074*
1,386
General and administrative
2,873
2,991
2,845*
2,545
Change in fair value of contingent consideration
2,284
-5,918
-3,327*
3,378
Impairment loss on held for sale assets
-
-
-
0
Impairment losses
-
-
3,650*
-
Total operating expenses
11,559
4,428
21,354*
11,187
Loss from operations
-11,402
-4,413
-19,789*
-11,048
Interest expense
-20
-23
-28*
-29
Other income, net
162
146
489*
223
Total other income, net
142
123
461*
194
Loss before income taxes
-11,260
-4,290
-19,328
-10,854
Net loss
-11,260
-4,290
-19,328
-10,854
Basic EPS
-0.31
-0.12
-0.706
-0.34
Diluted EPS
-0.31
-0.12
-0.706
-0.34
Basic Average Shares
36,750,000
34,519,000
27,372,000
32,033,000
Diluted Average Shares
36,750,000
34,519,000
27,372,000
32,033,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Net loss
-$11,260K
(-15.58%↓ Y/Y)
Other income, net
$162K
(29.60%↑ Y/Y)
Laboratory Services
$218K
(-55.87%↓ Y/Y)
Kitted Products
$21K
(-12.50%↓ Y/Y)
Loss before income
taxes
-$11,260K
(-15.58%↓ Y/Y)
Total other income,
net
$142K
(42.00%↑ Y/Y)
Net revenue
$239K
(-53.86%↓ Y/Y)
Interest expense
-$20K
(20.00%↑ Y/Y)
Loss from operations
-$11,402K
(-15.85%↓ Y/Y)
Gross profit
$157K
(-55.14%↓ Y/Y)
Cost of revenues
$82K
(-51.19%↓ Y/Y)
Total operating
expenses
$11,559K
(13.41%↑ Y/Y)
Research and development
$4,486K
(36.73%↑ Y/Y)
General and
administrative
$2,873K
(8.54%↑ Y/Y)
Change in fair value of
contingent consideration
$2,284K
(-18.54%↓ Y/Y)
Sales and marketing
$1,916K
(31.23%↑ Y/Y)
Buy us a coffee
Insight Molecular Diagnostics Inc. (IMDX)
Insight Molecular Diagnostics Inc. (IMDX)